Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App

Diabeloop receives FDA 510 (k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning ...

Dose of uncertainty: experts wary of AI health tech gadgets on display at CES trade show

Health tech gadgets displayed at the annual CES trade show make a lot of promises. A smart scale promoted a healthier ...
The BMJ

Ask an expert: Gout

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains four additional ...
MedTech Dive

FDA exempts more wearable, AI features from oversight

In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical ...

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...
The American Journal of Managed Care

Misalignment Between EHR Penicillin Allergy Flags, Allergist Assessments Signals Need for Improved Documentation

EHR documentation of penicillin allergies often misclassifies intolerances as allergies, leading to potential adverse outcomes from inappropriate antibiotic prescribing. The study found only 50.9% ...
Rheumatology Advisor

Obexelimab Significantly Reduces Flare Risk in IgG4-Related Disease

Topline data were announced from the phase 3 INDIGO trial evaluating obexelimab in adults with immunoglobulin G4-related disease.